Yi Tang

1.8k total citations
102 papers, 1.2k citations indexed

About

Yi Tang is a scholar working on Nephrology, Cardiology and Cardiovascular Medicine and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Yi Tang has authored 102 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 50 papers in Nephrology, 25 papers in Cardiology and Cardiovascular Medicine and 22 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Yi Tang's work include Renal Diseases and Glomerulopathies (35 papers), Chronic Kidney Disease and Diabetes (19 papers) and Pulmonary Hypertension Research and Treatments (10 papers). Yi Tang is often cited by papers focused on Renal Diseases and Glomerulopathies (35 papers), Chronic Kidney Disease and Diabetes (19 papers) and Pulmonary Hypertension Research and Treatments (10 papers). Yi Tang collaborates with scholars based in China, United States and Australia. Yi Tang's co-authors include Wei Qin, Jiaxing Tan, Gaiqin Pei, Wei Qin, Wei Peng, Ping Fu, Ling Zhang, Li Tan, Zheng Jiang and Yuliang Zhao and has published in prestigious journals such as Circulation, SHILAP Revista de lepidopterología and The Science of The Total Environment.

In The Last Decade

Yi Tang

98 papers receiving 1.2k citations

Peers

Yi Tang
Sahir Kalim United States
Su Ah Sung South Korea
Sung Jin Moon South Korea
Michele F. Eisenga Netherlands
Flaviu Bob Romania
Martin Busch Germany
Sahir Kalim United States
Yi Tang
Citations per year, relative to Yi Tang Yi Tang (= 1×) peers Sahir Kalim

Countries citing papers authored by Yi Tang

Since Specialization
Citations

This map shows the geographic impact of Yi Tang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yi Tang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yi Tang more than expected).

Fields of papers citing papers by Yi Tang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yi Tang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yi Tang. The network helps show where Yi Tang may publish in the future.

Co-authorship network of co-authors of Yi Tang

This figure shows the co-authorship network connecting the top 25 collaborators of Yi Tang. A scholar is included among the top collaborators of Yi Tang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yi Tang. Yi Tang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Shi, Xiaolei, Yi Tang, Xiang Wang, et al.. (2025). Associations of the Total Cholesterol/high-density Lipoprotein Cholesterol Ratio with Outcomes in Lupus Nephritis. International Journal of Medical Sciences. 22(10). 2398–2407.
2.
Jiang, Liang, Xiaojiang Chen, Jun Liao, et al.. (2025). Highly efficient removal of radioactive iodine from solution using in situ prepared Cu0@ACF adsorbent. The Science of The Total Environment. 998. 180279–180279.
3.
Xu, Qijiang, et al.. (2024). Random forest can accurately predict the technique failure of peritoneal dialysis associated peritonitis patients. Frontiers in Medicine. 10. 1335232–1335232. 2 indexed citations
4.
Tang, Yi, Jun Luo, Jingyuan Chen, et al.. (2023). Differential expression spectrum and targeted gene prediction of tRNA-derived small RNAs in idiopathic pulmonary arterial hypertension. Frontiers in Molecular Biosciences. 10. 1204740–1204740. 8 indexed citations
5.
Deng, J. S., et al.. (2023). Effectiveness of functional magnetic resonance imaging for early identification of chronic kidney disease: A systematic review and network meta-analysis. European Journal of Radiology. 160. 110694–110694. 9 indexed citations
6.
Jing, Ling, Minqi Li, Huiqi Zhao, et al.. (2022). Association Between Circulating Cell-Free DNA Level at Admission and the Risk of Heart Failure Incidence in Acute Myocardial Infarction Patients. DNA and Cell Biology. 41(8). 742–749. 5 indexed citations
7.
Tan, Jiaxing, Zheng Jiang, Gaiqin Pei, et al.. (2022). Probiotics ameliorate IgA nephropathy by improving gut dysbiosis and blunting NLRP3 signaling. Journal of Translational Medicine. 20(1). 382–382. 37 indexed citations
8.
Wang, Siqing, Zheng Jiang, Dandan Yang, et al.. (2022). Prognostic value of the albumin-to-fibrinogen ratio (AFR) in IgA nephropathy patients. International Immunopharmacology. 113(Pt A). 109324–109324. 5 indexed citations
9.
Pei, Gaiqin, Siqing Wang, Xiang Liu, et al.. (2022). Prognostic Value of Triglyceride to High-Density Lipoprotein Cholesterol Ratio (TG/HDL-C) in IgA Nephropathy Patients. Frontiers in Endocrinology. 13. 877794–877794. 14 indexed citations
10.
Jiang, Zheng, Jiang Liu, Lei Geng, et al.. (2021). The Influences of COVID-19 on Patients With Chronic Kidney Disease: A Multicenter Cross-Sectional Study. Frontiers in Psychiatry. 12. 754310–754310. 6 indexed citations
11.
Tan, Li, Yi Tang, Gaiqin Pei, et al.. (2021). A multicenter, prospective, observational study to determine association of mesangial C1q deposition with renal outcomes in IgA nephropathy. Scientific Reports. 11(1). 5467–5467. 15 indexed citations
12.
Wang, Siqing, Gaiqin Pei, Zheng Jiang, et al.. (2021). Cigarette smoking may accelerate the progression of IgA nephropathy. BMC Nephrology. 22(1). 239–239. 14 indexed citations
13.
Tang, Yi, Liyang Zhang, Wenlin Xie, et al.. (2020). A Novel Heterozygous Variant in F2 Gene in a Chinese Patient With Coronary Thrombosis and Acute Myocardial Infarction Leads to Antithrombin Resistance. Frontiers in Genetics. 11. 184–184. 4 indexed citations
14.
Pei, Gaiqin, et al.. (2020). Corticosteroids Improve Renal Survival: A Retrospective Analysis From Chinese Patients With Early-Stage IgA Nephropathy. Frontiers in Medicine. 7. 585859–585859. 4 indexed citations
15.
Peng, Wei, et al.. (2019). Crescents and Global Glomerulosclerosis in Chinese IgA Nephropathy Patients: A Five-Year Follow-Up. Kidney & Blood Pressure Research. 44(1). 103–112. 21 indexed citations
16.
Yuan, Ying, Liang Xu, Wei Yang, et al.. (2018). Analysis of anomalous origin of coronary arteries by coronary angiography in Chinese patients with coronary artery disease. International journal of cardiac imaging. 34(9). 1331–1337. 2 indexed citations
17.
Peng, Wei, et al.. (2018). Clinicopathological study of male and female patients with lupus nephritis: a retrospective study. International Urology and Nephrology. 50(2). 313–320. 15 indexed citations
18.
Zhao, Yuliang, Ling Zhang, Ying‐Ying Yang, et al.. (2016). Resolvin D1 Protects Lipopolysaccharide-induced Acute Kidney Injury by Down-regulating Nuclear Factor-kappa B Signal and Inhibiting Apoptosis. Chinese Medical Journal. 129(9). 1100–1107. 32 indexed citations
19.
Tang, Yi, Xiaoyan Zhang, Ling Ji, et al.. (2015). Clinicopathological and outcome analysis of adult lupus nephritis patients in China. International Urology and Nephrology. 47(3). 513–520. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026